Reporting by Nqobile Dludla
Editing by David Goodman and Miral Fahmy
An Aspen Pharmacare logo is seen at outside company offices in Woodmead, Johannesburg, South Africa, September 13, 2018. REUTERS/Siphiwe Sibeko/File Photo Acquire Licensing Rights
JOHANNESBURG, Dec 4 (Reuters) – Aspen Pharmacare (APNJ.J) is expanding further into China through a deal to buy the Chinese business of Swiss group Sandoz (SDZ.S) for up to 92.6 million euros ($100.6 million), the South African company said on Monday.
($1 = 0.9205 euros)
($1 = 18.7048 rand)
